Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synbionyme is a French dermo-cosmetic laboratory founded by Dr. Michel Bohbot, a pioneer in the field of dermatology and former founder of Bioderma. The company specializes in skincare solutions that focus on the skin's microbiota and its natural defense mechanisms. Their core innovation is the Pro-B3 system, a proprietary triple-action complex that combines prebiotics, probiotic extracts, and essential fatty acids to balance the skin's flora and strengthen the epidermis. Synbionyme offers a range of commercial products targeting various dermatological concerns, including aging, sensitivity, and acne-prone skin. The brand positions itself at the intersection of microbiology and dermatology to provide long-term skin health benefits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoire Synbionyme.